Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States

July 8, 2010 5:37 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM , July 8 /- Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United...

TOPICS:

New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets

July 8, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

DALLAS , July 8, 2010 /- According to a new market research report, 'Emerging Markets BRIC ( Brazil , Russia , India and China ) Patient Monitoring Market (2010 - 2015), published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the total BRIC patient monitoring devices market...

TOPICS:

Simple diagnostic tool predicts Type 2 diabetes in Southeast Asians

July 8, 2010 5:35 am | by EurekAlert | News | Comments

(Research Australia) Australian and Vietnamese researchers have estimated the current prevalence of Type 2 diabetes in Vietnam, and have developed a simple tool for identifying individuals at high risk.Often triggered by sedentary lifestyles and high-fat or high-sugar diets,...

TOPICS:
Advertisement

Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies

July 8, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

WATERLOO, Belgium , July 8, 2010 /- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R)...

TOPICS:

Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial

July 8, 2010 5:35 am | by Boston Scientific | News | Comments

NATICK, Mass., July 8 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in its MultiSENSE clinical trial. The trial is designed to evaluate multiple physiolog

TOPICS:

Guidance for HDE Holders, Institutional Review Boards (IRBs), Clinical Investigators, and Food and Drug Administration Staff - Humanitarian Device Exemption (HDE) Regulation: ...

July 8, 2010 5:32 am | by U.S. Food & Drug Administration | News | Comments

This guidance document answers commonly asked questions about Humanitarian Use Devices (HUDs) and applications for Humanitarian Device Exemption (HDE) authorized by section 510(m)(2) of the Federal Food, Drug, and Cosmetic Act (the Act). This guidance doc

TOPICS:

Alcon starts lawsuit trust, focuses on Novartis

July 8, 2010 2:45 am | by The Associated Press | News | Comments

Alcon Inc.'s Independent Director Committee said Thursday it created a litigation trust with $50 million for litigation related to any deal between Alcon and a majority shareholder, with a focus on Novartis.The trust was formed to provide funds to commence, defend or maintain a lawsuit....

Michael Garippa Joins SynCardia as President

July 8, 2010 12:34 am | by SynCardia | News | Comments

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Michael Garippa, the CEO and President of TandemHeart for the last 8 years, has left the company to become SynCardia's new president. Rodger Ford will continue as SynCardia's CEO,...

TOPICS:
Advertisement

1 in 4 Californian children have never seen a dentist, study finds

July 7, 2010 10:42 pm | by EurekAlert | News | Comments

(University of California - Los Angeles) A new UCLA Center for Health Policy Research study published in the July issue of Health Affairs reveals that in California, nearly 25 percent of children in the state have never seen a dentist and that disparities exist across race,...

TOPICS:

Startup Aims to Bring Useless Farmland Back to Life

July 7, 2010 10:41 pm | by Massachusetts Institute of Technology | News | Comments

The company is developing crops that tolerate salty soils.

Home care equivalent to hospital care for some patients with cystic fibrosis

July 7, 2010 10:36 pm | by EurekAlert | News | Comments

(American Thoracic Society) Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any...

TOPICS:

Multistep Diagnostics on Paper

July 7, 2010 10:35 pm | by Massachusetts Institute of Technology | News | Comments

A credit-card-sized diagnostic device can perform a task normally carried out by complex equipment.

TOPICS:

Multiplying DNA One Drop at a Time

July 7, 2010 10:34 pm | by Massachusetts Institute of Technology | News | Comments

RainDance Technologies says its method of amplifying DNA in drops of water will expand clinical genetic testing.

TOPICS:

Stryker to Host Conference Call on July 20, 2010

July 7, 2010 12:35 pm | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich. , July 7 /- Stryker Corporation (NYSE: SYK ) announced that it will host a conference call on Tuesday, July 20, 2010 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended June 30, 2010 , and provide an operational update. Operating...

TOPICS:

New 3-D imaging techniques for improved lung cancer drug development

July 7, 2010 12:32 pm | by EurekAlert | News | Comments

(Optical Society of America) Advanced imaging technologies that promise to improve effective drug development to treat lung cancer are the focus of the current issue of Optics Express, an open-access journal published by the Optical Society. Research outlines standardized...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading